Clinical and research tests for C0376358 AND 61756 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Results: 1 to 16 of 16

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
CancerNext® 37 Ambry Genetics United States	79	37	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Variant Resolution Test for CancerNext® 37 (+RNAinsight®) Ambry Genetics United States	79	18	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Variant Resolution Test for Penn Cancer Grant Panel (+RNAinsight®) Ambry Genetics United States	79	18	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Penn Cancer Grant Panel Ambry Genetics United States	79	80	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Variant Resolution Test for CancerNext® (+RNAinsight®) Ambry Genetics United States	36	39	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States	90	90	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®) Ambry Genetics United States	88	90	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
PTEN gene sequence and deletion/duplication Ambry Genetics United States	11	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CDH1 gene sequence and deletion/duplication Ambry Genetics United States	6	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CustomNext-Cancer® Ambry Genetics United States	94	90	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CHEK2 gene sequence and deletion/duplication Ambry Genetics United States	4	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CancerNext® Ambry Genetics United States	37	39	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CancerNext-Expanded® Ambry Genetics United States	86	89	D Deletion/duplication analysis C Sequence analysis of the entire coding region
BRCA1 and BRCA2 gene sequence and deletion/duplication Ambry Genetics United States	11	2	D Deletion/duplication analysis C Sequence analysis of the entire coding region
BRCA Portuguese 1-mutation panel specific site analysis Ambry Genetics United States	8	1	T Targeted variant analysis
BRCA Ashkenazi Jewish 3-mutation panel Ambry Genetics United States	11	2	T Targeted variant analysis

Results: 1 to 16 of 16

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.